Windtree Therapeutics Inc (NASDAQ:WINT)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - WINT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - WINT

  • Market Cap$99.500m
  • SymbolNASDAQ:WINT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS97382D3035

Company Profile

Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes a synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactant without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF that is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.Windtree Therapeutics Inc is a US-based development stage biotechnology company. It is focused on developing novel KL4 surfactant therapies for respiratory diseases and other potential applications.

Latest WINT news

Currently there for this company. Visit our news hub for other news .